학술논문
422 - MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic HCV Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure
Document Type
Abstract
Author
Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David R.; Hezode, Christophe; Lalezari, Jacob; Felizarta, Franco; Reindollar, Robert; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih-Wei; Lei, Yang; Ng, Teresa; Pilot-Matias, Tami; Kort, Jens; Mensa, Federico
Source
In Gastroenterology April 2017 152(5) Supplement 1:S1057-S1057
Subject
Language
ISSN
0016-5085